Condition
Vaccine Virus Shedding
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (2)
P 4 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01375647Phase 3Completed
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
NCT04941209Completed
imPulse™ Una Infrasound-to-ultrasound E-stethoscope
NCT04110366Not ApplicableCompleted
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
NCT02992197Phase 4Completed
The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity
NCT02477046Phase 3UnknownPrimary
Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh
Showing all 5 trials